ACADIA Pharmaceuticals Inc (ACAD) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACADIA Pharmaceuticals Inc (ACAD)

ACAD 22.75

+0.1%

11:49 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	4/30/2012 5:12:27 PM
	of 588

09:07 am ACADIA Pharmaceuticals initiated with a Buy at Ladenburg Thalmann: . Ladenburg Thalmann initiates ACAD with a Buy based on the prospects of pimavanserin's clinical development in Parkinson's disease psychosis. If the ongoing pimavanserin PDP pivotal trial is successful (September 2012), they believe investors should consider the potential of the drug not only in PDP, but also in other indications such as Alzheimer's disease psychosis (ADP), co-administration with antipsychotics in schizophrenia and others (on a risk-adjusted basis).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next